The minimally invasive surgery devices market is expected to grow from US$ 68.7 billion in 2022 to US$ 110.9 billion by 2028, at a CAGR of 10.2%. The growth of the market is attributed to factors such as the rising prevalence of chronic diseases, increasing adoption of MIS procedures, and technological advancements in MIS devices.

Minimally invasive surgery (MIS) is a type of surgery that uses smaller incisions than traditional surgery. This can lead to shorter hospital stays, less pain, and faster recovery times for patients. MIS devices are used to perform a variety of surgical procedures, including laparoscopic surgery, robotic surgery, and endoscopic surgery.

Request a Sample copy of this Report! https://bit.ly/3MiuETi

Key Drivers of the Minimally Invasive Surgery Devices Market:

  • Rising prevalence of chronic diseases: Chronic diseases such as cancer, cardiovascular diseases, and orthopedic disorders are the leading causes of death and disability worldwide. MIS is increasingly being used to treat these conditions, as it offers several advantages over traditional open surgery, such as less pain, faster recovery, and shorter hospital stays.
  • Increasing adoption of MIS procedures: MIS procedures are becoming increasingly popular among surgeons and patients alike. This is due to the several benefits that MIS offers, such as reduced blood loss, less tissue damage, and faster recovery.
  • Technological advancements in MIS devices: Technological advancements in MIS devices are making them more efficient and precise. For example, the development of robotic surgery systems has revolutionized MIS by enabling surgeons to perform complex procedures with greater accuracy and control.

Key Takeaways:

  • The minimally invasive surgery devices market is expected to grow from US$ 68.7 billion in 2022 to US$ 110.9 billion by 2028, at a CAGR of 10.2%.
  • The growth of the market is attributed to the increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and technological advancements in the field of minimally invasive surgery.
  • The gastrointestinal segment is expected to account for the largest share of the market during the forecast period, owing to the high prevalence of gastrointestinal disorders such as GERD, IBD, and colorectal cancer.
  • North America is expected to remain the largest market for minimally invasive surgery devices during the forecast period, due to the high adoption of minimally invasive procedures in the region.

Key Players:

  • Medtronic
  • Intuitive Surgical
  • Johnson & Johnson
  • Stryker
  • B. Braun Melsungen
  • Smith & Nephew
  • GE Healthcare
  • Siemens Healthineers
  • Olympus Corporation
  • Conmed Corporation
  • Boston Scientific

Segmentation:

By Product Type:

  • Orthopedic Minimally Invasive Surgery Devices
  • Cosmetic & Bariatric Minimally Invasive Surgery Devices
  • Gynecological Minimally Invasive Surgery Devices
  • Cardiothoracic Minimally Invasive Surgery Devices
  • Gastrointestinal Minimally Invasive Surgery Devices
  • Urological Minimally Invasive Surgery Devices
  • Minimally Invasive Surgery Devices for Other Disorders

By Application:

  • Hospitals
  • Clinics
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa